NAACCR Navigation Menu
Custom Search
Pathology Laboratory Electronic Reporting (Vol. V)
To aid with the implementation of Volume V compliant HL7 interfaces, the Pathology Data Work Group has developed a profile for the HL7 Messaging Work Bench (MWB). The MWB is a standalone application that can be used to validate the conformance of HL7 messages with the latest Volume V standard.”
Note: Because the OBX-5 data type is defined in Volume V as “Varies” the workbench will kick out an error “Invalid Data Type” if it encounters any values in OBX-5 that include component delimiters. In these situations the MWB will not validate properly until a conformance statement in the profile is defined with the explicit criteria for each different datatype. A resolution to this issue is currently being explored by the Pathology Data Work Group.
- Pathology Laboratory Electronic Reporting Version 3.0 (July 2009)
- Includes HL7 Version 2.5.1 Implementation Guidelines
- Pathology Laboratory Electronic Reporting Version 2.2 (Revised February 2009)
- Includes HL7 Version 2.3.1 Implementation Guidelines
- Electronic Pathology Reporting Guidelines (December 2006)
- Statement on Cancer Pathology Checklist Reports (May 2008)
- NAACCR Path Lab Search Terms - Search terms list for screening pathology reports test
- CAP Checklist Template Version Ckeys
To aid with the implementation of Volume V compliant HL7 interfaces, the Pathology Data Work Group has developed a profile for the HL7 Messaging Work Bench (MWB). The MWB is a standalone application that can be used to validate the conformance of HL7 messages with the latest Volume V standard.”
Note: Because the OBX-5 data type is defined in Volume V as “Varies” the workbench will kick out an error “Invalid Data Type” if it encounters any values in OBX-5 that include component delimiters. In these situations the MWB will not validate properly until a conformance statement in the profile is defined with the explicit criteria for each different datatype. A resolution to this issue is currently being explored by the Pathology Data Work Group.
This web-site is supported in part with Federal funds by Cooperative Agreement Number 5U58DP001803 from CDC. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the CDC. This web-site is also supported in part with Federal funds from the National Cancer Institute, National Institutes of Health, Department of Health and Human Services, under contract number HHSN261200900015C / ADB No. N02-PC-2009-00015. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NCI, NIH, or DHHS.